Literature DB >> 17549445

[The role of uveitis in demyelinating diseases of the central nervous system].

A-M Beyer1, B Rosche, U Pleyer, K P Wandinger.   

Abstract

An involvement of the visual system can be found in many neurologic diseases. Especially demyelinating processes of the central nervous system (CNS) and multiple sclerosis (MS) in particular present with a variety of ophthalmological abnormalities. While optic neuritis (ON) is known to be a positive predictor for the development of MS and can be considered a symptom of the disease, the high frequency of uveitis observed in MS patients seems to occur rather in the context of a general predisposition for autoimmune disorders. However, MS-associated uveitis can precede the onset of neurological symptoms by many years and shows response to treatment with steroids and interferons, suggesting the presence of similar underlying pathogenic mechanisms. Therefore, further studies are warranted in order to reveal whether administration of early immunomodulatory therapy can delay or even prevent the clinical manifestation of MS in a distinct subgroup of patients presenting with uveitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549445     DOI: 10.1007/s00115-007-2297-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  34 in total

1.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

2.  Treatment of autoimmune anterior uveitis with recombinant TCR ligands.

Authors:  Grazyna Adamus; Gregory G Burrows; Arthur A Vandenbark; Halina Offner
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

3.  Myelin basic protein specific T-helper cells induce experimental anterior uveitis.

Authors:  G Adamus; D Amundson; M Vainiene; K Ariail; M Machnicki; A Weinberg; H Offner
Journal:  J Neurosci Res       Date:  1996-06-15       Impact factor: 4.164

Review 4.  Optic neuritis and multiple sclerosis.

Authors:  M Söderström
Journal:  Acta Ophthalmol Scand       Date:  2001-06

5.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.

Authors:  E Bloch-Michel; R B Nussenblatt
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

6.  Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study.

Authors:  J F Rizzo; S Lessell
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

7.  Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests.

Authors:  A Ghezzi; V Martinelli; V Torri; M Zaffaroni; M Rodegher; G Comi; A Zibetti; N Canal
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

8.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.

Authors:  Roy W Beck; Jonathan D Trobe; Pamela S Moke; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; Edward G Buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A Goodwin; Barrett Katz; David I Kaufman; John L Keltner; Mark J Kupersmith; Neil R Miller; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Michael Wall
Journal:  Arch Ophthalmol       Date:  2003-07

9.  Retinal antigens are recognized by antibodies present in sera of patients with multiple sclerosis.

Authors:  Wojciech A Gorczyca; Maria Ejma; Danuta Witkowska; Marta Misiuk-Hojło; Marianna Kuropatwa; Małgorzata Mulak; Stanisław Szymaniec
Journal:  Ophthalmic Res       Date:  2004 Mar-Apr       Impact factor: 2.892

10.  Multiple sclerosis associated with uveitis in two large clinic-based series.

Authors:  V Biousse; C Trichet; E Bloch-Michel; E Roullet
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

View more
  2 in total

1.  [Intraocular inflammation in multiple sclerosis].

Authors:  N Stübiger; K Ruprecht; U Pleyer
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

Review 2.  [Uveitis in multiple sclerosis : Overview and perspectives].

Authors:  A L Hildebrandt; F Mackensen
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.